CIK 0001559053 · Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 011-353-1-236-2500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- 4 Planned sale Chief Scientific Officer sold 4,000 shares at an average $68.16 ($272,648)
- 4 Planned sale Director sold 5,000 shares at $67.43 ($337,150)
- 4 Planned sale Chief Legal Officer sold 5,000 shares at an average $69.82 ($349,118)
- 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $68.90 ($344,494)
- 4 Planned sale Chief Medical Officer sold 7,331 shares at $74.00 ($542,494)
- 4 Planned sale Chief Operating Officer sold 5,333 shares at an average $73.98 ($394,562)
- 4 Planned sale Chief Medical Officer sold 4,669 shares at an average $74.22 ($346,516)
- 4 Planned sale Chief Scientific Officer sold 19,000 shares at an average $71.06 ($1,350,224)
- 4 Planned sale Chief Regulatory Officer sold 20,000 shares at an average $71.05 ($1,421,009)
- 4 Planned sale Chief Legal Officer sold 5,000 shares at an average $64.64 ($323,223)
- 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $74.00 ($369,978)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 25 · 488 filings